VR Logo

Alembic Pharmaceuticals Ltd.


Healthcare | Drugs & Pharma

we think vacations are for wimps

38 Stocks to buy right now

Join Value Research Stock Advisor now and be among the first to discover Stock Ideas

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

About The Company

Business: Manufacture of allopathic pharmaceutical preparations

Incorporated: 2010

Chairman: Chirayu Amin

Managing Director: Shaunak Amin

Group: Alembic

Listing: NSE: APLLTD, BSE: 533573

Headquarters: Vadodara, Gujarat

Website: www.alembicpharmaceuticals.com

Key Facts

Market cap: R 16,919.30 Cr

Revenue (TTM): R 4,605.74 Cr

Earnings (TTM): R 800.66 Cr

Cash: R 205.62 Cr

Total Debt: R 1,128.43 Cr

Promoters' ownership: 72.97%

Liquidity: High

52 Week range: R 434.80 - 915.00

Face value: R2.00

Shares outstanding: 18,85,15,914

9 Years Aggregate:

  • CFO: 3,313.90 Cr
  • EBITDA: 4,450.91 Cr
  • Net Profit: 3,039.57 Cr

Stock Performance

Time Period Alembic Pharmaceuticals S&P BSE Healthcare S&P BSE Mid Cap
YTD57.1915.56-24.71
1 month40.852.59-2.57
3 months35.136.76-28.19
1 Year71.0216.76-23.19
3 Years14.382.02-7.98
5 Years10.61-1.901.19
10 Years--11.375.35
As on 22-May-2020
Year Alembic Pharmaceuticals S&P BSE Mid Cap S&P BSE Healthcare
2019-2.65-3.05-3.55
201812.95-13.31-5.89
2017-10.8448.130.49
2016-13.487.97-12.88
201556.357.4315.06
2014107.8254.6947.43
2013190.77-5.7322.55